Amendments to the General Regulation

Posted On: May 15, 2023

The Lieutenant Governor-in-Council has approved an amendment to the General Regulation (Ontario Regulation 168/15) made under the Naturopathy Act, 2007 to allow naturopaths access to additional drugs.  As of May 15, 2023, naturopathic doctors who have met the necessary standards of practice (Prescribing, IVIT) are authorized to access the following additional drugs as needed for patient care:

NEW Intravenous Infusion Therapy Drugs

Drug	Limitation
Alpha Lipoic Acid	Maximum daily dose of 600 mg for racemic form or 300 mg for R form.
Tyrosine (L-tyrosine)	Must be in combination with other amino acids.

 

NEW Route of Administration for Certain Drugs

Drug	Route of Administration
Vitamin B1	Intramuscular
Vitamin B2	Intramuscular
Vitamin B3	Intramuscular
Vitamin B5	Intramuscular
Vitamin B6	Intramuscular, subcutaneous

 

NEW Limitation for Prescribing, Dispensing, Compounding & Selling of Vitamin D

Drug	Limitation
Vitamin D	Only if prescribed, dispensed, compounded or sold in an oral dosage form containing more than 2,500 International Units of Vitamin D per dosage form or where the largest recommended daily dosage shown on the label would result in the daily intake by the patient of more than 2,500 International Units of Vitamin D.

 

As with the performance of any controlled act, Registrants must ensure that they have the necessary knowledge, skill and judgement to perform the procedure safely, competently and ethically, and that the administration or prescribing of any drug is necessary, in the best interest of the patient and in keeping with the Standards of Practice of the Profession.

Back to News & Announcements